So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
All content for EnRitched Menopause is the property of Jessica Ritch, MD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
Have you ever felt like you're stuck on autopilot, juggling responsibilities while putting yourself last? What if hitting pause could actually help you reset and come back stronger? In this episode, I sit down with wellness expert and yoga instructor Sonia Azad to talk about the power of rest, movement, and mindfulness - especially during perimenopause and menopause. After attending one of her retreats in Puerto Rico, I saw firsthand how slowing down can transform your well-bein...
EnRitched Menopause
So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
